Rare Diseases: Breaking Ground in Fibrosis and PAH

σε πρόσθεσε στο Wellness

2025-12-24 11:26:15 -

While asthma and COPD represent the "volume," the "value" and innovation are occurring in rare respiratory diseases like Idiopathic Pulmonary Fibrosis (IPF) and Pulmonary Arterial Hypertension (PAH). These conditions have historically had very poor survival rates, but 2025 marks a turning point with the introduction of "Disease-Modifying" therapies. The Respiratory Drugs Market analysis...

0 Σχόλια 0 Μοιράστηκε 10 Views 0 Προεπισκόπηση